Deep Track Capital, LP — STRUCTURE THERAPEUTICS INC. GPCR: Quarterly 13F Position History
Deep Track Capital, LP has reported STRUCTURE THERAPEUTICS INC. (GPCR) on 13 13F-HR filings in Pactolio's tracked window, first appearing in Q1 2023. As of Q1 2026, the position is sized at 4,279,848 shares ($206.3M market value, 4.26% of the equity book). Quarter-over-quarter share count change: + 168,066 (+4.1%) .
- 4,279,848Shares Held (Latest Filing)
- $206.3MReported Market Value (Latest Filing)
- 4.26%Portfolio Weight (% of 13F Equity Book)
- +168,066Quarter-over-Quarter Share Change
- -$79.7MQuarter-over-Quarter Value Change
- 5,133,917Peak Reported Shares (Historical)
Quarterly 13F-HR Disclosure History Source: SEC 13F-HR filings, 13 quarter s
| Quarter | Shares | QoQ Share Change | Share Change (%) | Market Value | Weight | Implied Price |
|---|---|---|---|---|---|---|
| Q1 2026 | 4,279,848 | +168,066 | +4.1% | $206.3M | 4.26% | $48.20 |
| Q4 2025 | 4,111,782 | 104,029 | -2.5% | $286.0M | 6.52% | $69.55 |
| Q3 2025 | 4,215,811 | 918,106 | -17.9% | $118.0M | 3.29% | $28.00 |
| Q2 2025 | 5,133,917 | +1,033,917 | +25.2% | $106.5M | 3.42% | $20.74 |
| Q1 2025 | 4,100,000 | +1,300,000 | +46.4% | $71.0M | 2.30% | $17.31 |
| Q4 2024 | 2,800,000 | +1,579,492 | +129.4% | $75.9M | 2.85% | $27.12 |
| Q3 2024 | 1,220,508 | +270,508 | +28.5% | $53.6M | 1.71% | $43.89 |
| Q2 2024 | 950,000 | +909,863 | +2266.9% | $37.3M | 1.11% | $39.27 |
| Q1 2024 | 40,137 | 259,863 | -86.6% | $1.7M | 0.05% | $42.86 |
| Q4 2023 | 300,000 | 1,615,000 | -84.3% | $12.2M | 0.43% | $40.76 |
| Q3 2023 | 1,915,000 | 731,782 | -27.6% | $96.6M | 3.74% | $50.42 |
| Q2 2023 | 2,646,782 | 0 | — | $110.0M | 5.14% | $41.57 |
| Q1 2023 | 2,646,782 | — | — | $63.0M | 2.68% | $23.79 |
Methodology & FAQ
How This Position History Is Sourced
Each row is one SEC Form 13F-HR filing disclosing this position. Share count, market value, and reported quarter are taken verbatim from the filing; portfolio weight is recomputed against the same filing's total reported equity book. Implied price-per-share is market value divided by shares — a quarter-end mark, not the manager's cost basis. See the full methodology document for the normalization rules.
When did Deep Track Capital, LP first disclose a GPCR position in 13F-HR filings?
Deep Track Capital, LP first reported STRUCTURE THERAPEUTICS INC. (GPCR) on its 13F-HR filing for the period ending 2023-03-31 (Q1 2023). The position has appeared on 13 reported quarters within Pactolio's tracked window.
What was Deep Track Capital, LP's most recent quarter-over-quarter share-count change in GPCR?
Between Q4 2025 and Q1 2026, Deep Track Capital, LP added 168,066 shares of GPCR (+4.1%), bringing the total reported position to 4,279,848 shares at a market value of $206.3M.
Does the implied price-per-share represent Deep Track Capital, LP's cost basis in GPCR?
No. The implied price-per-share column is the 13F-HR reported market value divided by reported share count on the filing date (end of quarter). It is a quarter-end mark, not a cost basis or transaction price. Use it as a sanity check on the value column, not as an indicator of the manager's entry or exit price.